Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698918 | Clinical Oncology | 2015 | 8 Pages |
Abstract
Local ablative treatment seemed to improve the overall survival of the patients who presented with oligometastatic sarcomas, including soft tissue and bone sarcomas. The survival benefit remained after repeated local treatments for several oligometastatic events. Surgery yielded the most relevant results, but alternative approaches (i.e. radiofrequency ablation and radiotherapy) seemed to be promising. The relevance of these results is strengthened by our analysis, which avoided biases by restricting the population to patients with oligometastatic disease and used propensity scores.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.T. Falk, L. Moureau-Zabotto, M. Ouali, N. Penel, A. Italiano, J.-O. Bay, T. Olivier, M.-P. Sunyach, P. Boudou-Roquette, S. Salas, C. Le Maignan, A. Ducassou, N. Isambert, E. Kalbacher, C. Pan, E. Saada, F. Bertucci, A. Thyss, J. Thariat,